share_log

HC Wainwright & Co. Initiates Coverage On Instil Bio With Buy Rating, Announces Price Target of $2

HC Wainwright & Co. Initiates Coverage On Instil Bio With Buy Rating, Announces Price Target of $2

HC Wainwright & Co.以買入評級啓動Instil Bio的報道,宣佈目標股價爲2美元
Benzinga ·  2023/06/29 06:10

HC Wainwright & Co. analyst Mitchell Kapoor initiates coverage on Instil Bio (NASDAQ:TIL) with a Buy rating and announces Price Target of $2.

HC Wainwright & Co. 分析師米切爾·卡普爾啓動了對Instil Bio(納斯達克股票代碼:TIL)的報道,評級爲買入,並宣佈目標股價爲2美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論